全文获取类型
收费全文 | 1935篇 |
免费 | 150篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 86篇 |
妇产科学 | 43篇 |
基础医学 | 215篇 |
口腔科学 | 59篇 |
临床医学 | 237篇 |
内科学 | 463篇 |
皮肤病学 | 47篇 |
神经病学 | 149篇 |
特种医学 | 264篇 |
外科学 | 159篇 |
综合类 | 29篇 |
一般理论 | 1篇 |
预防医学 | 149篇 |
眼科学 | 18篇 |
药学 | 85篇 |
中国医学 | 8篇 |
肿瘤学 | 71篇 |
出版年
2023年 | 20篇 |
2022年 | 17篇 |
2021年 | 47篇 |
2020年 | 20篇 |
2019年 | 29篇 |
2018年 | 67篇 |
2017年 | 33篇 |
2016年 | 38篇 |
2015年 | 42篇 |
2014年 | 57篇 |
2013年 | 67篇 |
2012年 | 80篇 |
2011年 | 81篇 |
2010年 | 74篇 |
2009年 | 76篇 |
2008年 | 91篇 |
2007年 | 71篇 |
2006年 | 77篇 |
2005年 | 52篇 |
2004年 | 50篇 |
2003年 | 64篇 |
2002年 | 50篇 |
2001年 | 55篇 |
2000年 | 40篇 |
1999年 | 38篇 |
1998年 | 57篇 |
1997年 | 61篇 |
1996年 | 69篇 |
1995年 | 55篇 |
1994年 | 50篇 |
1993年 | 50篇 |
1992年 | 26篇 |
1991年 | 21篇 |
1990年 | 25篇 |
1989年 | 47篇 |
1988年 | 38篇 |
1987年 | 39篇 |
1986年 | 44篇 |
1985年 | 35篇 |
1984年 | 23篇 |
1983年 | 12篇 |
1982年 | 22篇 |
1981年 | 14篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1975年 | 13篇 |
1969年 | 4篇 |
排序方式: 共有2093条查询结果,搜索用时 31 毫秒
1.
Ángel Becerra Héctor Trujillo Lucía Valencia Aurelio Rodríguez‐Pérez 《Brazilian Journal of Anesthesiology》2019,69(2):200-203
Background and objectives
A prompt and effective management of trauma patient is necessary. The aim of this case report is to highlight the importance of intraoperative echocardiography as a useful tool in patients suffering from refractory hemodynamic instability no otherwise explained.Case report
A 41 year‐old woman suffered a car accident. At the emergency department, no abnormalities were found in ECG or chest X‐ray. Abdominal ultrasound revealed the presence of abdominal free liquid and the patient was submitted to urgent exploratory laparotomy. Nevertheless, she persisted suffering arterial hypotension and metabolic acidosis. Looking for the reason of her hemodynamic instability, intraoperative transthoracic echocardiography was performed, finding out the presence of pericardial effusion. Once the cardiac surgeon extracted pericardial clots, patient's situation improved clinically and analytically.Conclusion
Every anesthesiologist should be able to use the intraoperative echocardiography as an effective tool in order to establish the appropriate measures to promote the survival of patients suffering severe trauma. 相似文献2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
A Parra F Gabi?o A Ramírez H Valencia I Coria A Espinosa de los Monteros 《Contraception》1991,44(5):541-547
The study was undertaken to analyze the basal and metoclopramide-stimulated serum PRL levels in healthy parous women users (group 1, n = 12) and non-users (group 2, n = 12) of a TCu-380 IUD. All women had regular menses and were studied between days 18 to 22 of their cycle; none had lactated nor regularly ingested any type of medication during the last six months. After a 10-12 hour overnight fast, peripheral venous blood samples were obtained through an indwelling catheter at -30, -15 and 0 minutes and at 60, 90 and 120 minutes after oral metoclopramide (10 mg). There were no significant differences in serum PRL between both groups, in basal levels nor throughout the test, whether analyzing the mean values at each sampling time, the sum of PRL levels from 60-120 minutes, or the peak levels. No correlation was observed between PRL levels and any of the clinical or obstetric characteristics of the women in both groups. Serum progesterone was greater than or equal to 4.0 ng/ml in all women. Thus, the use of alpha TCu-380 IUD did not induce any significant changes in basal nor in stimulated serum PRL levels. 相似文献
4.
5.
6.
7.
8.
9.
10.
Kristine Jones Ph.D. Paul Colson Ph.D. Elie Valencia J.D. Ezra Susser M.D. Dr.P.H. 《The Psychiatric quarterly》1994,65(4):243-256
The Critical Time Intervention Project is a three-year clinical trial which tests a time-limited, supportive intervention
to reduce recurrent homelessness among mentally ill men moving from a shelter to the community. Along with a comparison of
nights spent homeless and other outcomes, the evaluation of the Critical Time Intervention includes a comparison of the relative
costs of the intervention, compared to usual treatment. Such cost effectiveness analyses are difficult to perform and are
rarely applied to mental health treatments. This paper presents the general scheme of this analysis and discusses critical
issues in the construction and measurement of cost variables. Preliminary results which have implications for the cost analysis
are presented. 相似文献